<DOC>
	<DOCNO>NCT01417195</DOCNO>
	<brief_summary>The objective study compare fertilization rate combination Menopur Bravelle mixed syringe Menopur alone , administer subcutaneously ( SC ) , subject undergoing Assisted Reproductive Technology ( ART ) . Additionally study assessed subject ' ability mix store combination Menopur Bravelle ass safety Menopur Bravelle combination .</brief_summary>
	<brief_title>Menopur Mixed Protocol</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Menotropins</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Main Infertile premenopausal female subject Documented history infertility ( eg. , unable conceive least 1 year , 6 month woman ≥36 year age , woman bilateral tubal occlusion absence , subject require donor sperm ) . Subject 's male partner semen analysis least adequate intracytoplasmic sperm injection ( ICSI ) within 6 month prior subject begin downregulation gonadotropinreleasing hormone ( GnRH ) agonist . Partners severe male factor require invasive surgical sperm retrieval donor sperm could use . Antimullerian hormone ( AMH ) &gt; 1 ng/mL &lt; 3 ng/mL screening . Eligible invitro fertilisation ( IVF ) ICSI treatment . Main Oocyte donor embryo recipient ; gestational surrogate carrier Previous IVF assist reproductive technology ( ART ) failure due poor response gonadotropin . Poor response define development ≤ 2 mature follicle history 2 previous fail cycle cancellation prior oocyte retrieval due poor response . Inadequate number oocyte , define few 5 oocyte retrieve previous ART attempt . Subject 's male partner obvious leukospermia ( &gt; 2 million white blood cell [ WBC ] /mL ) sign infection semen sample within 2 month start subject 's pituitary downregulation . If either condition exist , male treat antibiotic retested prior subject 's pituitary downregulation . Undergoing blastomere biopsy experimental ART procedure . Body mass index ( BMI ) ≤18 ≥32 kg/m^2</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Assisted Reproductive Technology</keyword>
</DOC>